XML 35 R28.htm IDEA: XBRL DOCUMENT
v3.21.4

SHARE EXCHANGE AND ASSIGNMENT (Narrative) (Details) - PsilocybinLabs Ltd [Member] | Aug. 07, 2019 CAD ($) Shares shares | Apr. 25, 2019 CAD ($) shares
--- | --- | ---
Share Exchange And Assignment [Line Items] |  |
Number of shares issued by PL to individual | shares |  | 100,000
Value of common stock issued by PL to individual | $ |  | $ 2,000
Common shares purchased | shares | 100,000 |
Number of shares issued | Shares | 100,000 |
Value of common stock shares issued | $ | $ 2,000 |

X
- Definition Represents the number of common stock shares purchased. + References No definition available. + Details
Name: | drug_CommonStockSharesPurchased
Namespace Prefix: | drug_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Represents the number of shares issued by related party. + References No definition available. + Details
Name: | drug_NumberOfSharesIssuedByRelatedParty
Namespace Prefix: | drug_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table. + References No definition available. + Details
Name: | drug_ShareExchangeAndAssignmentLineItems
Namespace Prefix: | drug_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the value of common stock shares issued by related party. + References No definition available. + Details
Name: | drug_ValueOfCommonStockSharesIssuedByRelatedParty
Namespace Prefix: | drug_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2020-01-01 -Paragraph B64 -Subparagraph f -Clause iv -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2020-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B -URIDate 2020-01-01 + Details
Name: | ifrs-full_EquityInterestsOfAcquirer
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2020-01-01 -Paragraph B64 -Subparagraph f -Clause iv -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2020-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B -URIDate 2020-01-01 + Details
Name: | ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=drug_PsilocybinlabsLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |